PancreaKare Powder DIN (Canada)

Company: Solvet

Pancrelipase Powder

For veterinary use only

DIN: 02543664

Active Ingredients

Each 2.8 g (1 teaspoon) contains:

Each 2.8 g (1 teaspoon) digests:

Warnings: Avoid inhaling the product. Exercise caution during handling and measuring of product if you have a known allergy to proteins of porcine origin. Keep out of reach of children.

PancreaKare Powder DIN Indications

For replacement therapy in conditions due to exocrine pancreatic insufficiency in dogs and cats.

Dosage and Administration

Administer orally. Mix powder with pet’s food 20 minutes before eating.

Dogs: 2.8-4.2g (1-1 1/2 tsp) with each meal.

Cats: 1.4-2.1g (1/2-3/4 tsp) with each meal.

Dosage is dependent on degree of pancreatic insufficiency. Consult your veterinarian for frequency of meals and adjustment of dosage.

PancreaKare Powder DIN Caution

Discontinue use if symptoms of sensitivity occur.

Storage

Store the container tightly closed in a dry place between 15-30°C.

One teaspoon scoop is provided with each container.

Manufactured by: Alberta Veterinary Laboratories Ltd. 7226 107 Ave SE, Calgary, Alberta, Canada 1-877-456-2755

Solvet™ is a trademark of Alberta Veterinary Laboratories Ltd.

115 g, 12 x 115 g

CPN: 1973047.0